Welcome to LookChem.com Sign In|Join Free

CAS

  • or

509093-77-0

Post Buying Request

509093-77-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Benzamide, 3-nitro-N-[1-phenyl-5-(1-piperidinylmethyl)-1H-benzimidazol-2-yl]-

    Cas No: 509093-77-0

  • No Data

  • No Data

  • No Data

  • yuyongmei
  • Contact Supplier

509093-77-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 509093-77-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,9,0,9 and 3 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 509093-77:
(8*5)+(7*0)+(6*9)+(5*0)+(4*9)+(3*3)+(2*7)+(1*7)=160
160 % 10 = 0
So 509093-77-0 is a valid CAS Registry Number.

509093-77-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-nitro-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide

1.2 Other means of identification

Product number -
Other names N-(1-Phenyl-5-piperidin-1-ylmethyl-1H-benzoimidazol-2-yl)-3-nitro-benzamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:509093-77-0 SDS

509093-77-0Downstream Products

509093-77-0Relevant articles and documents

Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4

Wang, Zhulun,Sun, Daqing,Johnstone, Sheree,Cao, Zhaodan,Gao, Xiong,Jaen, Juan C.,Liu, Jingqian,Lively, Sarah,Miao, Shichang,Sudom, Athena,Tomooka, Craig,Walker, Nigel P.C.,Wright, Matthew,Yan, Xuelei,Ye, Qiuping,Powers, Jay P.

, p. 5546 - 5550 (2015/11/17)

In this Letter, we report the continued optimization of the N-acyl-2-aminobenzimidazole series, focusing in particular on the N-alkyl substituent and 5-position of the benzimidazole based on the binding mode and the early SAR. These efforts led to the discovery of 16, a highly potent, selective, and orally bioavailable inhibitor of IRAK-4.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 509093-77-0